Strategies for reducing child mortality due to sickle cell disease in Uganda: a narrative review
- PMID: 40486550
- PMCID: PMC12140782
- DOI: 10.1097/MS9.0000000000002981
Strategies for reducing child mortality due to sickle cell disease in Uganda: a narrative review
Abstract
Sickle cell disease (SCD) remains a significant contributor to child mortality in Uganda, with an estimated 80% of children born with SCD dying before their fifth birthday, largely due to lack of early diagnosis and inadequate access to comprehensive care. Neonatal screening, although critical for early detection, is limited in Uganda, with coverage rates below 10%. This lack of early diagnosis often leads to delayed treatment and higher mortality rates. Data from recent studies highlight that implementing universal newborn screening could reduce SCD-related mortality by up to 50% if coupled with timely interventions such as prophylactic antibiotics, vaccination, and parental education. Comprehensive care, which includes regular health check-ups, preventive care, pain management, and access to blood transfusions, is essential for improving survival rates among children with SCD. However, in Uganda, only 30% of children with SCD receive regular follow-up care, and access to life-saving interventions like blood transfusions remains limited, especially in rural areas. A study conducted in Uganda found that children with SCD who received regular blood transfusions had a 70% lower risk of stroke and other severe complications compared to those who did not. Strengthening healthcare infrastructure and increasing access to these critical services are crucial to reducing mortality. Community engagement and education play a vital role in reducing SCD-related child mortality. Despite the high burden of SCD, awareness levels among Ugandan communities remain low, contributing to delayed healthcare-seeking behavior and high mortality rates.
Keywords: child mortality; comprehensive care; early diagnosis; health system strengthening; sickle cell disease.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. The author declares no conflict of interest.
Similar articles
-
Public-private partnerships in tackling sickle cell disease in Uganda: a narrative review.Ann Med Surg (Lond). 2025 May 21;87(6):3339-3355. doi: 10.1097/MS9.0000000000003082. eCollection 2025 Jun. Ann Med Surg (Lond). 2025. PMID: 40486578 Free PMC article. Review.
-
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.Cochrane Database Syst Rev. 2020 Apr 6;4(4):CD012389. doi: 10.1002/14651858.CD012389.pub3. Cochrane Database Syst Rev. 2020. PMID: 32250453 Free PMC article.
-
Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.Cochrane Database Syst Rev. 2018 Aug 1;8(8):CD012082. doi: 10.1002/14651858.CD012082.pub2. Cochrane Database Syst Rev. 2018. PMID: 30067867 Free PMC article.
-
Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa.Semin Hematol. 2023 Sep;60(4):192-199. doi: 10.1053/j.seminhematol.2023.08.002. Epub 2023 Aug 24. Semin Hematol. 2023. PMID: 37730472 Free PMC article.
-
A Retrospective Analysis of Demographics, Clinical Features, and Treatment Patterns in Sickle Cell Disease Patients at a Tertiary Healthcare Centre of North East India.Cureus. 2024 Nov 26;16(11):e74489. doi: 10.7759/cureus.74489. eCollection 2024 Nov. Cureus. 2024. PMID: 39726467 Free PMC article.
References
-
- Kato GJ, Piel FB, Reid CD, et al. . Sickle cell disease. Nat Rev Dis Primers 2018;4:1–22. - PubMed
-
- Hernandez AG. Effective strategies used to describe and address the burden of sickle cell disease in the Republic of Uganda: The Uganda Sickle Surveillance Study (Master’s thesis, University of Cincinnati). 2016.
Publication types
LinkOut - more resources
Full Text Sources